Results 131 to 140 of about 9,845,002 (301)

Cancer Trends: Breast cancer 1994-2016

, 2019
There were 62,052 cases of newly diagnosed invasive or in situ breast tumours registered in Ireland by the National Cancer Registry for the period 1994–2016, of which 56,366 were invasive (ICD10: C50) and 5,686 were carcinoma in situ (ICD10: D05 ...
National Cancer Registry Ireland (NCRI)
core  

Health Risk Assessment of Occupational Exposure to BTEX in the Painting unit of a Bicycle Industry in Quchan, Iran

تحقیقات سلامت در جامعه, 2020
Introduction and purpose: Benzene, Toluene, Ethylbenzene, and Xylenes (BTEX) is regarded as one of the most important pollutants in organic compounds present in paint compounds the toxic effects of which are well known.
Mahmoud Mohammadyan, Hadi Naderi, Seyed Nouraddin Mousavinasab, Hadi Mahmoodi sharafe, Ali Rafiei, Mohammad Dasturani   +5 more
doaj  

Finding novel vulnerabilities of hypomorphic BRCA1 alleles

Molecular Oncology, EarlyView.
Synthetic lethality screens performed to identify novel vulnerabilities often model complete gene loss, thereby overlooking patient‐derived hypomorphic mutations. In this study, we have performed genome‐wide CRISPR screens on BRCA1 hypomorphic mutations, showing BRCA1I26A behaves like wild‐type, while BRCA1R1699Q mimics deficiency. Furthermore, we have
Anne Schreuder, Klaas de Lint, Hồ Mỹ Phúc Võ, Mariana M. Góis, Rosalie A. Kampen, Marta San Martin Alonso, Ilse Nootenboom, Veronica Garzero, Tiemen J. Wendel, Rob M. F. Wolthuis, Sylvie M. Noordermeer   +10 more
wiley   +1 more source

Risks of Cancer and Families [PDF]

JNCI: Journal of the National Cancer Institute, 2005
openaire   +2 more sources

MITF maintains genome stability in nonmelanocyte lineages

Molecular Oncology, EarlyView.
MITF is essential for melanocyte survival and acts as an oncogene in 10%–20% of melanomas. We show that MITF depletion causes genome instability in nonmelanocytic cells, leading to LATS2‐mediated P53 activation, cell cycle arrest, and apoptosis. This study highlights the role of MITF as a genome maintenance factor beyond the melanocyte lineage. Created
Drifa H. Gudmundsdottir, Adrián López García de Lomana, Thejus B. Venkatesh, Kritika Kirty, Snaevar Sigurdsson, Linda Vidarsdottir, Ramile Dilshat, Erla Sveinbjornsdottir, Snaedis Ragnarsdottir, Daniel H Magnusson, Maria R. Bustos, Eirikur Steingrimsson, Thorkell Gudjonsson, Stefan Sigurdsson   +13 more
wiley   +1 more source

Case-Case Genome-Wide Analyses Identify Subtype-Informative Variants That Confer Risk for Breast Cancer.

Breast cancer includes several subtypes with distinct characteristic biological, pathologic, and clinical features. Elucidating subtype-specific genetic etiology could provide insights into the heterogeneity of breast cancer to facilitate the development
Knight, JA, John, EM, Hu, JJ, Buas, MF, Reiner, AS, Cai, Q, Pal, T, Jia, G, Derkach, A, Chen, Y, Ambrosone, CB, Olopade, OI, Chen, J, Press, MF, Shu, X, Gu, J, Ping, J, Sandler, DP, Zheng, W, Haiman, CA, Offit, K, Wang, X, Nemesure, B, Troester, MA, Palmer, JR, Guo, X, Nathanson, KL, Garcia-Closas, M, Shu, X-O, Woods, M, Yang, Y, Watt, GP, Sanderson, M, Liang, X, Ambs, S, Concannon, P, Verma, SP, Huo, D, Bernstein, JL, Oh, JH, Lynch, CF, Olshan, AF, Long, J, Li, CI, Sun, X, Mellemkjær, L   +45 more
core   +1 more source

Loss of proton‐sensing TDAG8 increases tumor progression in mouse models of colon cancer

Molecular Oncology, EarlyView.
Loss of the pH‐sensing receptor TDAG8 accelerates colorectal cancer progression in mice. Animals lacking TDAG8 expression had increased tumor growth, DNA damage, and recruitment of tumor‐associated immune cells, including macrophages, neutrophils, and monocytes.
Ermanno Malagola, Yasmine Illi, Anna Bircher, Marijn Wilmink, Rachele F. Malagutti, Solenn Ottié, Cordelia Schuler, Pedro A. Ruiz, Cheryl de Vallière, Klaus Seuwen, Gerhard Rogler, Martin Hausmann   +11 more
wiley   +1 more source

Calculation of Cancer Risk [PDF]

Environmental Health Perspectives, 1997
openaire   +2 more sources

Epigenetic heterogeneity and plasticity in therapy‐induced tumor states through single‐cell multi‐omics

Molecular Oncology, EarlyView.
Single‐cell multi‐omics reveals epigenetic heterogeneity across therapy‐adaptive tumor states, including quiescent/dormant, drug‐tolerant persister, and EMT‐like phenotypes. By linking regulatory features with state‐associated biomarkers, these approaches inform biomarker‐guided therapeutic strategies for evolving tumors.
Hee Jung Kim, Hwiyeong Lee, Jin Hong, Daechan Park   +3 more
wiley   +1 more source

Cancer Trends: HPV-associated cancers

, 2017
Chronic infection with oncogenic (tumour-causing) strains of human papillomavirus (HPV) is now well-established as an important risk factor for anogenital (cervical, vaginal, vulvar, penile and anal/rectal) and head and neck (specifically oropharyngeal ...
National Cancer Registry Ireland (NCRI)
core